Megan Smeykal's most recent trade in TELA Bio Inc was a trade of 32,850 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 32,850 | 69,681 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. | 18 Feb 2026 | 1,590 | 67,296 (0%) | 0% | 0.7 | 1,141 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.79 per share. | 18 Feb 2026 | 795 | 68,886 (0%) | 0% | 0.8 | 632 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.77 per share. | 18 Feb 2026 | 423 | 66,873 (0%) | 0% | 0.8 | 324 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.22 per share. | 31 Mar 2025 | 96 | 36,831 (0%) | 0% | 1.2 | 117 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 1,590 | 37,889 (0%) | 0% | 2.7 | 4,325 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 21 Feb 2025 | 539 | 36,927 (0%) | 0% | 2.6 | 1,428 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.72 per share. | 21 Feb 2025 | 423 | 37,466 (0%) | 0% | 2.7 | 1,151 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 9,400 | 39,479 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.67 per share. | 31 Mar 2024 | 96 | 29,000 (0%) | 0% | 5.7 | 544 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 539 | 29,096 (0%) | 0% | 7.1 | 3,811 | Common Stock |
| TELA Bio Inc | Smeykal Megan | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.07 per share. | 23 Feb 2024 | 423 | 29,635 (0%) | 0% | 7.1 | 2,991 | Common Stock |
| TELA Bio Inc | Smeykal Megan | Chief Accounting Officer, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 9,400 | 30,058 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.00 per share. | 21 Feb 2024 | 795 | 20,658 (0%) | 0% | 7 | 5,565 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.64 per share. | 31 Mar 2023 | 96 | 20,431 (0%) | 0% | 10.6 | 1,021 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.03 per share. | 23 Feb 2023 | 539 | 20,527 (0%) | 0% | 11.0 | 5,945 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. | 23 Feb 2023 | 423 | 21,066 (0%) | 0% | 10.5 | 4,442 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 9,400 | 21,489 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.63 per share. | 31 Mar 2022 | 93 | 12,089 (0%) | 0% | 11.6 | 1,082 | Common Stock |
| TELA Bio Inc | Megan Smeykal | Chief Accounting Officer, Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.98 per share. | 24 Feb 2022 | 535 | 12,182 (0%) | 0% | 12.0 | 6,409 | Common Stock |